Where do Capricor Therapeutics's ratios come from?

Every ratio is computed from Capricor Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	FY'25	FY'24	FY'23	FY'22
Returns
Return on equity	-46.6%+1.6pp	-48.2%+81.5pp	-129.6%+4.9pp	-134.5%-67.3pp
Return on assets	-39.9%-4.6pp	-35.3%+5.6pp	-41%+22.5pp	-63.5%-10.8pp
Return on invested capital	-128.7%-71.6pp	-57.1%+169pp	-226.3%+340pp	-566.3%—
Efficiency
Asset turnover	0×-0.2×	0.2×-0.3×	0.5×—	——
Liquidity
Current ratio	9×+1.2×	7.8×+6.1×	1.6×-0.2×	1.8×-7.0×
Quick ratio	9×+1.2×	7.8×+6.1×	1.6×-0.2×	1.8×-7.0×
Cash ratio	8×+7.5×	0.5×+0.1×	0.5×+0.1×	0.4×-8.0×
Leverage
Debt-to-equity	0×0.0×	0×-0.2×	0.2×-0.2×	0.5×+0.3×
Debt-to-assets	0×0.0×	0×-0.1×	0.1×0.0×	0.1×0.0×
Interest coverage	-35.5×—	——	——	——
Per Share
Book value per share	$6.58+59.3%	$4.13+389%	$0.84+75.8%	$0.48-64.7%
Valuation
Market capitalization	$1.57B+150%	$627.48M+317%	$150.58M+54.5%	$97.43M+37.7%
Enterprise value	$1.3B+110%	$617.65M+337%	$141.49M+51.5%	$93.4M+122%
Price / book	5.1×+0.8×	4.3×-2.3×	6.7×-1.6×	8.3×+6.0×
Free cash flow yield	-4.6%+1.9pp	-6.6%+11.3pp	-17.9%—	——
Earnings yield	-6.7%-0.2pp	-6.4%+8.4pp	-14.8%+15.0pp	-29.8%-1.5pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Capricor Therapeutics's ratios come from?: Every ratio is computed from Capricor Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.